Literature DB >> 10945806

Repetitive speech phenomena in Parkinson's disease.

T Benke1, C Hohenstein, W Poewe, B Butterworth.   

Abstract

OBJECTIVES: Repetitive speech phenomena are morphologically heterogeneous iterations of speech which have been described in several neurological disorders such as vascular dementia, progressive supranuclear palsy, Wilson's disease, and Parkinson's disease, and which are presently only poorly understood. The present, prospective study investigated repetitive speech phenomena in Parkinson's disease to describe their morphology, assess their prevalence, and to establish their relation with neuropsychological and clinical background data.
METHODS: Twenty four patients with advanced Parkinson's disease and 29 subjects with mid-stage, stable idiopathic disease were screened for appearance, forms, and frequency of repetitive speech phenomena, and underwent a neuropsychological screening procedure comprising tests of general mental functioning, divergent thinking and memory. Patients with advanced Parkinson's disease had a significantly higher disease impairment, longer disease duration, and an unstable motor response to levodopa with frequent on-off fluctuations. Both groups were well matched as to their demographical, clinical, and cognitive background. Perceptual speech evaluation was used to count and differentiate forms of repetitive speech phenomena in different speech tasks. To compare the effect of the motor state, the appearance of repetitive speech phenomena was also assessed in a subgroup of patients with advanced Parkinson's disease during the on versus the off state.
RESULTS: Speech repetitions emerged mainly in two variants, one hyperfluent, formally resembling palilalia, and one dysfluent, stuttering-like. Both forms were present in each patient producing repetitive speech phenomena. The repetitive speech phenomena appeared in 15 patients (28.3 %), 13 of whom belonged to the advanced disease group, indicating a significant preponderance of repetitive speech phenomena in patients with a long term, fluctuating disease course. Repetitive speech phenomena appeared with almost equal frequency during the on and the off state of patients with advanced Parkinson's disease. Their distribution among different variants of speech was disproportional, with effort demanding speech tasks producing a significantly higher number of repetitive speech phenomena over semiautomatic forms of speech.
CONCLUSIONS: In idiopathic Parkinson's disease repetitive speech phenomena seem to emerge predominantly in a subgroup of patients with advanced disease impairment; manifest dementia is not a necessary prerequisite. They seem to represent a deficit of motor speech control; however, linguistic factors may also contribute to their generation. It is suggested that repetitions of speech in Parkinson's disease represent a distinctive speech disorder, which is caused by changes related to the progression of Parkinson's disease.

Entities:  

Mesh:

Year:  2000        PMID: 10945806      PMCID: PMC1737094          DOI: 10.1136/jnnp.69.3.319

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Palilalia.

Authors:  F Boller; M Albert; F Denes
Journal:  Br J Disord Commun       Date:  1975-10

3.  Differential diagnostic patterns of dysarthria.

Authors:  F L Darley; A E Aronson; J R Brown
Journal:  J Speech Hear Res       Date:  1969-06

4.  Acquired stuttering.

Authors:  N A Helm; R B Butler; D F Benson
Journal:  Neurology       Date:  1978-11       Impact factor: 9.910

5.  Prosodic disturbance and neurologic lesion.

Authors:  R D Kent; J C Rosenbek
Journal:  Brain Lang       Date:  1982-03       Impact factor: 2.381

Review 6.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

7.  Language and speech in a patient with a clinical diagnosis of progressive supranuclear palsy.

Authors:  Y Lebrun; F Devreux; J J Rousseau
Journal:  Brain Lang       Date:  1986-03       Impact factor: 2.381

8.  Dysfluency (stuttering) in extrapyramidal disease.

Authors:  W C Koller
Journal:  Arch Neurol       Date:  1983-03

9.  Neuropsychological characteristics of preclinical dementia in Parkinson's disease.

Authors:  D M Jacobs; K Marder; L J Côté; M Sano; Y Stern; R Mayeux
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

Review 10.  Speech disorders of Parkinsonism: a review.

Authors:  E M Critchley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-09       Impact factor: 10.154

View more
  16 in total

1.  Dramatic effects of speech task on motor and linguistic planning in severely dysfluent parkinsonian speech.

Authors:  Diana Van Lancker Sidtis; Krista Cameron; John J Sidtis
Journal:  Clin Linguist Phon       Date:  2012-08       Impact factor: 1.346

2.  Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.

Authors:  Jan Rusz; Roman Cmejla; Hana Růžičková; Jiří Klempíř; Veronika Majerová; Jana Picmausová; Jan Roth; Evžen Růžička
Journal:  J Neural Transm (Vienna)       Date:  2012-07-08       Impact factor: 3.575

Review 3.  Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.

Authors:  Manju A Kurian; Susan J Hayflick
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

Review 4.  Neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

5.  Effect of Levodopa on Speech Dysfluency in Parkinson's Disease.

Authors:  Hannah Im; Scott Adams; Anita Abeyesekera; Marcus Pieterman; Greydon Gilmore; Mandar Jog
Journal:  Mov Disord Clin Pract       Date:  2018-12-30

6.  Face-referenced measurement of perioral stiffness and speech kinematics in Parkinson's disease.

Authors:  Shin Ying Chu; Steven M Barlow; Jaehoon Lee
Journal:  J Speech Lang Hear Res       Date:  2015-04       Impact factor: 2.297

7.  Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.

Authors:  Jan Rusz; Cecilia Bonnet; Jiří Klempíř; Tereza Tykalová; Eva Baborová; Michal Novotný; Aaron Rulseh; Evžen Růžička
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

8.  Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.

Authors:  Takashi Tsuboi; Hirohisa Watanabe; Yasuhiro Tanaka; Reiko Ohdake; Makoto Hattori; Kazuya Kawabata; Kazuhiro Hara; Mizuki Ito; Yasushi Fujimoto; Daisuke Nakatsubo; Satoshi Maesawa; Yasukazu Kajita; Masahisa Katsuno; Gen Sobue
Journal:  J Neural Transm (Vienna)       Date:  2017-11-02       Impact factor: 3.575

9.  Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease.

Authors:  Sabine Skodda; Wenke Visser; Uwe Schlegel
Journal:  J Neural Transm (Vienna)       Date:  2009-12-12       Impact factor: 3.575

10.  Acquired stuttering after pallidal deep brain stimulation for dystonia.

Authors:  Adelheid Nebel; Rene Reese; Günther Deuschl; Hubertus-Maximilian Mehdorn; Jens Volkmann
Journal:  J Neural Transm (Vienna)       Date:  2009-01-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.